Global Epigenetics Market 2022 Business Scenario - Merck KGaA (Germany), PerkinElmer (US), Qiagen (Germany), Diagenode (Germany)
The global epigenetics market is projected to reach USD 3.9 Billion by 2027 from USD 1.7 Billion in 2022, at a CAGR of 18.1%
